Twelve weeks of treatment with empagliflozin in patients with heart failure and reduced ejection fraction: A double-blinded, randomized, and placebo-controlled trial.
Jensen J, Omar M, Kistorp C, Poulsen MK, Tuxen C, Gustafsson I, Køber L, Gustafsson F, Faber J, Fosbøl EL, Bruun NE, Brønd JC, Forman JL, Videbæk L, Møller JE, Schou M.
Jensen J, et al. Among authors: gustafsson f, gustafsson i.
Am Heart J. 2020 Oct;228:47-56. doi: 10.1016/j.ahj.2020.07.011. Epub 2020 Jul 17.
Am Heart J. 2020.
PMID: 32798787
Free article.
Clinical Trial.